Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation ExpenseEBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuances
Ratios

Collegium Pharmaceutical (COLL) Other Gross PP&E Adjustments (2016 - 2026)

Collegium Pharmaceutical has reported Other Gross PP&E Adjustments over the past 11 years, most recently at $15.9 million for Q4 2025.

  • For Q4 2025, Other Gross PP&E Adjustments rose 10.38% year-over-year to $15.9 million; the TTM value through Dec 2025 reached $15.9 million, up 10.38%, while the annual FY2025 figure was $15.9 million, 10.38% up from the prior year.
  • Other Gross PP&E Adjustments for Q4 2025 was $15.9 million at Collegium Pharmaceutical, up from -$59.9 million in the prior quarter.
  • Over five years, Other Gross PP&E Adjustments peaked at $18.9 million in Q4 2023 and troughed at -$172.0 million in Q1 2025.
  • A 5-year average of -$51.6 million and a median of -$52.3 million in 2022 define the central range for Other Gross PP&E Adjustments.
  • Biggest five-year swings in Other Gross PP&E Adjustments: soared 62.58% in 2021 and later tumbled 1285.56% in 2022.
  • Year by year, Other Gross PP&E Adjustments stood at $12.9 million in 2021, then skyrocketed by 31.78% to $17.0 million in 2022, then increased by 11.19% to $18.9 million in 2023, then fell by 23.83% to $14.4 million in 2024, then grew by 10.38% to $15.9 million in 2025.
  • Business Quant data shows Other Gross PP&E Adjustments for COLL at $15.9 million in Q4 2025, -$59.9 million in Q3 2025, and -$116.2 million in Q2 2025.